Literature DB >> 20200239

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.

Lin Liu1, Brian E Fisher, Kimberly A Dowd, Jacquie Astemborski, Andrea L Cox, Stuart C Ray.   

Abstract

During the transition from acute to chronic infection in individuals persistently infected with hepatitis C virus (HCV), cellular responses initiate within the first 6 months of primary infection and collapse thereafter, whereas humoral responses activate later during the chronic phase. Whether and how this deviation of immune responses specifically influences HCV evolution are unknown. To determine the pattern of HCV evolution during this critical period, we conducted extensive sequence analysis on annual clonal hemigenomic sequences for up to 3 years in six well-characterized subjects, using statistical methods that accounted for repeated measures. Significantly different evolutionary rates were observed in envelope versus nonenvelope genes, with an increasing rate of nonsynonymous change (dN) in envelope genes and a stable dN in nonenvelope genes (P = 0.006). The ratio of the envelope to nonenvelope nonsynonymous rate increased from 2 in year 1 to 5 in years 2 and 3. Centripetal changes (reversions toward matching of the worldwide subtype 1a consensus sequence) were frequently observed during the 3-year transition from acute infection to chronicity, even in the presence of neutralizing antibody (NAb) pressure. Remarkably, sequences of hypervariable region 1 (HVR1) remained stable for up to 21 months in the absence of NAb pressure in one subject, followed by rapid changes that were temporally associated with the detection of NAb responses, which strongly suggests that HVR1 evolution is shaped by NAb pressure. These data provide the first systematic estimates of HCV evolutionary rates in multiple genes during early infection in vivo and provide additional evidence for deterministic, rather than random, evolution of HCV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200239      PMCID: PMC2863818          DOI: 10.1128/JVI.02265-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.

Authors:  Alleluiah Rutebemberwa; Stuart C Ray; Jacquie Astemborski; Jordana Levine; Lin Liu; Kimberly A Dowd; Shalyn Clute; Changyu Wang; Alan Korman; Alessandro Sette; John Sidney; Drew M Pardoll; Andrea L Cox
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.

Authors:  Xiao-Hong Wang; Dale M Netski; Jacquie Astemborski; Shruti H Mehta; Michael S Torbenson; David L Thomas; Stuart C Ray
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

3.  Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.

Authors:  Shadi Salloum; Cesar Oniangue-Ndza; Christoph Neumann-Haefelin; Laura Hudson; Silvia Giugliano; Marc aus dem Siepen; Jacob Nattermann; Ulrich Spengler; Georg M Lauer; Manfred Wiese; Paul Klenerman; Helen Bright; Norbert Scherbaum; Robert Thimme; Michael Roggendorf; Sergei Viazov; Joerg Timm
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

4.  Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.

Authors:  Christoph Sarrazin; Tara L Kieffer; Doug Bartels; Brian Hanzelka; Ute Müh; Martin Welker; Dennis Wincheringer; Yi Zhou; Hui-May Chu; Chao Lin; Christine Weegink; Henk Reesink; Stefan Zeuzem; Ann D Kwong
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

Review 5.  Hepatitis C virus entry and neutralization.

Authors:  Zania Stamataki; Joe Grove; Peter Balfe; Jane A McKeating
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

6.  Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.

Authors:  Christoph Neumann-Haefelin; David N Frick; Jing Jing Wang; Oliver G Pybus; Shadi Salloum; Gagandeep S Narula; Anna Eckart; Andrea Biezynski; Thomas Eiermann; Paul Klenerman; Sergei Viazov; Michael Roggendorf; Robert Thimme; Markus Reiser; Jörg Timm
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

7.  Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.

Authors:  Zhen-yong Keck; Sophia H Li; Jinming Xia; Thomas von Hahn; Peter Balfe; Jane A McKeating; Jeroen Witteveldt; Arvind H Patel; Harvey Alter; Charles M Rice; Steven K H Foung
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.

Authors:  Jennifer M Timpe; Zania Stamataki; Adam Jennings; Ke Hu; Michelle J Farquhar; Helen J Harris; Anne Schwarz; Isabelle Desombere; Geert Leroux Roels; Peter Balfe; Jane A McKeating
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 9.  Acute hepatitis C.

Authors:  Anurag Maheshwari; Stuart Ray; Paul J Thuluvath
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

10.  Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.

Authors:  Jens Bukh; Robert Thimme; Jean-Christophe Meunier; Kristina Faulk; Hans Christian Spangenberg; Kyong-Mi Chang; William Satterfield; Francis V Chisari; Robert H Purcell
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

View more
  45 in total

1.  Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.

Authors:  Weihua Wang; Jianguo Lin; De Tan; Yanjuan Xu; Elizabeth M Brunt; Xiaofeng Fan; Adrian M Di Bisceglie
Journal:  Biochem Biophys Res Commun       Date:  2011-09-16       Impact factor: 3.575

2.  Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks.

Authors:  Rebecca Rose; Christopher Rodriguez; James Jarad Dollar; Susanna L Lamers; Guido Massaccesi; William Osburn; Stuart C Ray; David L Thomas; Andrea L Cox; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2019-02-22       Impact factor: 3.342

3.  A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Authors:  Adam Zuiani; Kevin Chen; Megan C Schwarz; James P White; Vincent C Luca; Daved H Fremont; David Wang; Matthew J Evans; Michael S Diamond
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome.

Authors:  Supriya Munshaw; Justin R Bailey; Lin Liu; William O Osburn; Kelly P Burke; Andrea L Cox; Stuart C Ray
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

5.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

6.  Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.

Authors:  Patrizia Farci; Kurt Wollenberg; Giacomo Diaz; Ronald E Engle; Maria Eliana Lai; Paul Klenerman; Robert H Purcell; Oliver G Pybus; Harvey J Alter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-24       Impact factor: 11.205

7.  Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure.

Authors:  Justin R Bailey; Sarah Laskey; Lisa N Wasilewski; Supriya Munshaw; Liam J Fanning; Elizabeth Kenny-Walsh; Stuart C Ray
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

8.  HIV populations are large and accumulate high genetic diversity in a nonlinear fashion.

Authors:  Frank Maldarelli; Mary Kearney; Sarah Palmer; Robert Stephens; JoAnn Mican; Michael A Polis; Richard T Davey; Joseph Kovacs; Wei Shao; Diane Rock-Kress; Julia A Metcalf; Catherine Rehm; Sarah E Greer; Daniel L Lucey; Kristen Danley; Harvey Alter; John W Mellors; John M Coffin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

Review 9.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 10.  Prospects for prophylactic hepatitis C vaccines based on virus-like particles.

Authors:  Elodie Beaumont; Philippe Roingeard
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.